EICHORPublic-registry site landscape for NCT04524949, “IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)”, a Diabetes Mellitus, Type 1 study sponsored by Imcyse SA. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04524949 (registry record) |
| Study title | IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study) |
| Official title | A Phase IIa, Randomized, Double-blind, Dose Comparison, Placebo-controlled, Multi-centre Clinical Trial to Evaluate the Immune Signature of the Treatment With the Imotope IMCY-0098 and Its Effect on the Preservation of Beta-cell Function in Adult Patients With a Recent Onset Type 1 Diabetes |
| Sponsor | Imcyse SA |
| Condition(s) | Diabetes Mellitus, Type 1 |
| Phase | PHASE2 |
| Listed sites | 29 |
| Site countries | United States, Australia, Belgium, Italy, Lithuania, Slovenia, Sweden, United Kingdom |
Patient-friendly overview of this study: eichor.com/study/NCT04524949.
Eichor generates a preliminary site-risk snapshot for NCT04524949 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Diabetes Mellitus, Type 1 trials
← Eichor home · All tracked trials · Diabetes Mellitus, Type 1 studies · Weekly briefs
